Condition: Nephrotoxicity · Sponsor: Tanta University
The goal of this clinical trial is to assess the possible reno-protective effect of L-carnitine against cisplatin-induced nephrotoxicity in patients receiving cisplatin-based chemotherapy. The main question it aims to answer is: Does L-carnitine have the ability to protect the kidney against cisplatin-induced nephrotoxicity?
This description comes directly from the study's public registry record.
Fatma M Eweda, Master · +201017045245 · fatma.mamdouh7376@phrm.menofia.edu.eg
Fatma M Eweda · fatmamamdouh203@gmail.com
Always discuss trial participation with your own doctor first.
| Menoufia Clinical Oncology Department, Menoufia University. | Shibīn al Kawm, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07108777